Public health actions to control new SARS-CoV-2 variants Comment

被引：107

作者：

Grubaugh, Nathan D. ^{[1
,2
,3
]}

Hodcroft, Emma B. ^{[4
]}

Fauver, Joseph R. ^{[1
]}

Phelan, Alexandra L. ^{[5
,6
]}

Cevik, Muge ^{[7
]}

机构：

[1] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA

[2] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA

[3] Yale Univ, Yale Inst Global Hlth, New Haven, CT USA

[4] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland

[5] Georgetown Univ, Ctr Global Hlth Sci & Secur, Washington, DC 20057 USA

[6] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20057 USA

[7] Univ St Andrews, Sch Med, Div Infect & Global Hlth Res, St Andrews, Fife, Scotland

来源：

CELL | 2021年 / 184卷 / 05期

关键词：

D O I：

10.1016/j.cell.2021.01.044

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Recent reports suggest that some SARS-CoV-2 genetic variants, such as B.1.1.7, might be more transmissible and are quickly spreading around the world. As the emergence of more transmissible variants could exacerbate the pandemic, we provide public health guidance for increased surveillance and measures to reduce community transmission.

引用

页码：1127 / 1132

页数：6

共 14 条

[1]

[Anonymous], 2020, NY TIMES

[2] Angiotensin-converting enzyme 2 is an essential regulator of heart function [J].

Crackower, MA ;

Sarao, R ;

Oudit, GY ;

Yagil, C ;

Kozieradzki, I ;

Scanga, SE ;

Oliveira-dos-Santos, AJ ;

da Costa, J ;

Zhang, LY ;

Pei, Y ;

Scholey, J ;

Ferrario, CM ;

Manoukian, AS ;

Chappell, MC ;

Backx, PH ;

Yagil, Y ;

Penninger, JM .

NATURE, 2002, 417 (6891) :822-828

[3] Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England [J].

Davies, Nicholas G. ;

Abbott, Sam ;

Barnard, Rosanna C. ;

Jarvis, Christopher, I ;

Kucharski, Adam J. ;

Munday, James D. ;

Pearson, Carl A. B. ;

Russell, Timothy W. ;

Tully, Damien C. ;

Washburne, Alex D. ;

Wenseleers, Tom ;

Gimma, Amy ;

Waites, William ;

Wong, Kerry L. M. ;

van Zandvoort, Kevin ;

Silverman, Justin D. ;

Diaz-Ordaz, Karla ;

Keogh, Ruth ;

Eggo, Rosalind M. ;

Funk, Sebastian ;

Jit, Mark ;

Atkins, Katherine E. ;

Edmunds, W. John .

SCIENCE, 2021, 372 (6538) :149-+

[4]

Devi S, 2020, LANCET, V395, P1331, DOI 10.1016/S0140-6736(20)30967-3

[5]

Greaney A. J., 2021, bioRxiv, DOI [DOI 10.1101/2020.12.31.425021, 10.1101/2020.12.31.425021.]

[6]

Grepin KA, 2020, EVIDENCE EFFECTIVENE, V2020, DOI [10.1101/2020.11.23.20236703, DOI 10.1101/2020.11.23.20236703]

[7]

Kemp S A, 2020, medRxiv, DOI 10.1101/2020.12.05.20241927

[8] Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus [J].

Korber, Bette ;

Fischer, Will M. ;

Gnanakaran, Sandrasegaram ;

Yoon, Hyejin ;

Theiler, James ;

Abfalterer, Werner ;

Hengartner, Nick ;

Giorgi, Elena E. ;

Bhattacharya, Tanmoy ;

Foley, Brian ;

Hastie, Kathryn M. ;

Parker, Matthew D. ;

Partridge, David G. ;

Evans, Cariad M. ;

Freeman, Timothy M. ;

de Silva, Thushan, I ;

McDanal, Charlene ;

Perez, Lautaro G. ;

Tang, Haili ;

Moon-Walker, Alex ;

Whelan, Sean P. ;

LaBranche, Celia C. ;

Saphire, Erica O. ;

Montefiori, David C. .

CELL, 2020, 182 (04) :812-+

[9] Genetic Variants of SARS-CoV-2-What Do They Mean? [J].

Lauring, Adam S. ;

Hodcroft, Emma B. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (06) :529-531

[10]

PHE, 2020, J NEUROL

← 1 2 →